Lipocine Inc (LPCN): Next-Year EPS Estimate 32.67%
As of 2026-04-13, Lipocine Inc (LPCN) has a next-year EPS growth estimate of 32.67%.
On 2026-03-31, analyst consensus for LPCN's next-year EPS growth shifted from 38.22% to 32.67% — a negative change of 5.55 percentage points. The revised estimate has been sustained across 17 subsequent trading sessions. Current-year growth is projected at -18.64%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 32.67%
- EPS growth this year
- -18.64%
- EPS next quarter (est)
- -$0.48
- Last price
- $2.39
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-04-13 | 32.67% | -18.64% | -$0.48 | $2.39 |
| 2026-04-12 | 32.67% | -18.64% | -$0.48 | $2.20 |
| 2026-04-10 | 32.67% | -18.64% | -$0.48 | $2.16 |
| 2026-04-09 | 32.67% | -18.64% | -$0.48 | $2.09 |
| 2026-04-08 | 32.67% | N/A | -$0.48 | $2.13 |
| 2026-04-07 | 32.67% | N/A | -$0.48 | $2.00 |
| 2026-04-06 | 32.67% | N/A | -$0.48 | $2.00 |
| 2026-04-05 | 32.67% | N/A | -$0.48 | $2.05 |
| 2026-04-03 | 32.67% | N/A | -$0.48 | $2.00 |
| 2026-04-02 | 32.67% | N/A | -$0.48 | $2.00 |
| 2026-04-01 | 32.67% | N/A | -$0.48 | $2.00 |
| 2026-04-01 | 32.67% | N/A | N/A | $9.25 |
| 2026-04-01 | 32.67% | N/A | N/A | $9.25 |
| 2026-04-01 | 32.67% | N/A | N/A | $9.25 |
| 2026-03-31 | 32.67% | N/A | N/A | $7.99 |
| 2026-03-31 | 32.67% | N/A | N/A | $7.99 |
| 2026-03-31 | 32.67% | N/A | N/A | $7.99 |
| 2026-03-30 | 38.22% | N/A | N/A | $7.58 |
| 2026-03-30 | 32.67% | N/A | N/A | $7.58 |
| 2026-03-30 | 32.67% | N/A | N/A | $7.58 |
| 2026-03-29 | 38.22% | N/A | N/A | $7.15 |
| 2026-03-29 | 38.22% | N/A | N/A | $7.15 |
| 2026-03-27 | 38.22% | N/A | N/A | $7.15 |
| 2026-03-26 | 38.22% | N/A | N/A | $7.40 |
| 2026-03-26 | 38.22% | N/A | N/A | $7.40 |
| 2026-03-26 | 38.22% | N/A | N/A | $7.40 |
| 2026-03-25 | 38.22% | N/A | N/A | $7.43 |
| 2026-03-25 | 38.22% | N/A | N/A | $7.43 |
| 2026-03-25 | 38.22% | N/A | N/A | $7.43 |
| 2026-03-24 | 38.22% | N/A | N/A | $7.36 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Lipocine Inc's next-year EPS growth estimate?▾
As of 2026-04-13, Lipocine Inc (LPCN) has a next-year EPS growth estimate of 32.67%, based on analyst consensus.
When was the latest EPS estimate revision for LPCN?▾
The most recent revision occurred on 2026-03-31, when analysts adjusted the next-year EPS growth estimate from 38.22% to 32.67%.
What sector and industry does Lipocine Inc belong to?▾
Lipocine Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LPCN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Lipocine Inc (LPCN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports